Taylor Frigon Capital Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.96M Sell
19,718
-105
-0.5% -$13.7K 1.12% 44
2025
Q4
$2.41M Sell
19,823
-941
-5% -$118K 1.22% 29
2025
Q3
$2.33M Sell
20,764
-307
-1% -$35.9K 1.16% 40
2025
Q2
$2.82M Sell
21,071
-10,469
-33% -$1.15M 1.5% 11
2025
Q1
$2.12M Buy
31,540
+6,922
+28% +$476K 1.26% 25
2024
Q4
$1.53M Buy
+24,618
New +$2.29M 0.78% 65

Other funds holding TMDX

Taylor Frigon Capital Management's TMDX Position: Q1 2026 in Review

Taylor Frigon Capital Management reduced its Transmedics (TMDX) stake by 0.53% in Q1 2026, selling an estimated $13.7K and leaving 19,718 shares worth $1.96M. The position accounts for 1.12% of the portfolio, ranked #44.

Taylor Frigon Capital Management first reported a position in TMDX in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.82M in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Taylor Frigon Capital Management held 19,718 shares of Transmedics worth $1.96M as of Q1 2026.
  • Taylor Frigon Capital Management sold 105 Transmedics shares in Q1 2026, an estimated $13.7K.
  • Transmedics made up 1.12% of Taylor Frigon Capital Management's portfolio in Q1 2026, its #44 holding.
  • Taylor Frigon Capital Management first reported a position in Transmedics in Q4 2024 and has held it in 6 quarters since.
  • Taylor Frigon Capital Management's Transmedics position peaked at $2.82M in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Taylor Frigon Capital Management's 13F filing for Q1 2026, filed 29 Apr 2026.